TITLE

Reduced adherence to antiretroviral therapy among patients on antiretroviral therapy in Limpopo province, South Africa

AUTHOR(S)
MAKUA, T.
PUB. DATE
June 2015
SOURCE
African Journal for Physical, Health Education, Recreation & Dan;2015Supplement, Vol. 21, p107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The purpose of this study was to explore the determining factors for reduced adherence to antiretroviral therapy (ART) for HIV positive patients on ART residing in Polokwane, in Limpopo Province of South Africa. This study made use of the generic qualitative research design and in-depth qualitative interviews to collect data from a purposive sample of patients who did not adhere to ART. Thematic content analysis was used to analyse the data collected from the 18 patients from four clinics in Polokwane offering ART to patients. The participants attributed their reduced adherence to service delivery, patients' socio-economic status and family factors. The socio-economic status such as unemployment and abuse of alcohol leading to forgetfulness to take ART was among the factors cited by participants. Failure to disclose the health status to the family was indicated as the reason for reduced adherence to the treatment. None or partial adherence can lead to the development of drug-resistant strains of the virus. Health education on ART would assist the patients with managing the stigmatisation. In order to increase the understanding of the effects of alcohol on the ART, a lot of efforts need to be put on educating the patients about such interaction.
ACCESSION #
110326526

 

Related Articles

  • A prospective study of predictors of adherence to combination antiretroviral medication. Golin, Carol E.; Liu, Honghu; Hays, Ron D.; Miller, Loren G.; Beck, C. Keith; Ickovics, Jeanette; Kaplan, Andrew H.; Wenger, Neil S. // JGIM: Journal of General Internal Medicine;Oct2002, Vol. 17 Issue 10, p756 

    Objective: Adherence to complex antiretroviral therapy (ART) is critical for HIV treatment but difficult to achieve. The development of interventions to improve adherence requires detailed information regarding barriers to adherence. However, short follow-up and inadequate adherence...

  • The Safety and Efficacy of Enfuvirtide Therapy for HIV Infection in Patients with Hemophilia: A Case Series. Polizzotto, Mark N.; Street, Alison M.; Wright, Edwina // Clinical Infectious Diseases;8/15/2007, Vol. 45 Issue 4, pe39 

    The treatment of patients with human immmunodeficiency virus (HIV) infection and hemophilia involves unique challenges that may be addressed with novel antiretroviral classes. We describe the safety and efficacy of enfuvirtide therapy in 4 patients with severe hemophilia A. Although local skin...

  • Self-reported signs of lipodystrophy by persons living with HIV infection. Dreezen, C.; Schrooten, W.; De Mey, I.; Goebel, F. D.; Dedes, N.; Florence, E.; Colebunders, R.; Eurosupport Study Group // International Journal of STD & AIDS;Jun2002, Vol. 13 Issue 6, p393 

    Objective: To identify risk factors for the development of lipodystrophy in HIV infected patients on highly active antiretroviral therapy.Methods: A survey among patients with HIV infection using an anonymous questionnaire was conducted in 10 European countries between...

  • Treatment of Mycobacterium avium Complex Immune Reconstitution Disease in HIV-1-Infected Individuals. Desimone, Joseph A.; Babinchak, Timothy J.; Kaulback, Kris R.; Pomerantz, Roger J. // AIDS Patient Care & STDs;Dec2003, Vol. 17 Issue 12, p617 

    Immune reconstitution disease caused by Mycobacterium avium complex (MAC) infection presenting shortly after the introduction of highly active antiretroviral therapy (HAART) has been reported with increasing frequency in persons with HIV-1 infection during the past several years. Several...

  • Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials. Steigbigel, Roy T.; Cooper, David A.; Teppler, Hedy; Eron, Joseph J.; Gatell, Jose M.; Kumar, Princy N.; Rockstroh, Jurgen K.; Schechter, Mauro; Katlama, Christine; Markowitz, Martin; Yeni, Patrick; Loutfy, Mona R.; Lazzarin, Adriano; Lennox, Jeffrey L.; Clotet, Bonaventura; Jing Zhao; Hong Wan; Rhodes, Rand R.; Strohmaier, Kim M.; Barnard, Richard J. // Clinical Infectious Diseases;2/15/2010, Vol. 50 Issue 4, p605 

    BENCHMRK-1 and -2 are ongoing double-blind phase III studies of raltegravir in patients experiencing failure of antiretroviral therapy with triple-class drug-resistant human immunodeficiency virus infection. At week 96 (combined data), raltegravir (400 mg twice daily) plus optimized background...

  • Predictors of Virological Outcome and Safety in Primary HIV Type 1—Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005. Hoen, Bruno; Cooper, David A.; Lampe, Fiona C.; Perrin, Luc; Clumeck, Nathan; Phillips, Andrew N.; Goh, Li-Ean; Lindback, Stefan; Sereni, Daniel; Gazzard, Brian; Montaner, Julio; Stellbrink, Hans-Jurgen; Lazzarin, Adriano; Ponscarme, Diane; Staszewski, Shlomo; Mathiesen, Lars; Smith, Don; Finlayson, Robert; Weber, Rainer; Wegmann, Laurence // Clinical Infectious Diseases;8/1/2007, Vol. 45 Issue 3, p381 

    Background. Initiation of antiretroviral therapy during primary human immunodeficiency virus (HIV)-1 infection may confer long-term benefit. Methods. After initiation of zidovudine, lamivudine, abacavir, and amprenavir therapy in patients in the QUEST cohort, predictors of virological outcome,...

  • HIV “Elite Controllers” Are Characterized by a High Frequency of Memory CD8+CD73+ T Cells Involved in the Antigen-Specific CD8+ T-cell Response. Carrière, Matthieu; Lacabaratz, Christine; Kök, Ayrin; Benne, Clarisse; Jenabian, Mohammad-Ali; Casartelli, Nicoletta; Hüe, Sophie; Hocqueloux, Laurent; Lelièvre, Jean-Daniel; Lévy, Yves // Journal of Infectious Diseases;May2014, Vol. 209 Issue 9, p1321 

    Human immunodeficiency virus type 1 (HIV-1) infection is characterized by chronic immune activation and suppressed T-lymphocyte functions. Here we report that CD73, both a coactivator molecule of T cells and an immunosuppressive ecto-enzyme through adenosine production, is only weakly expressed...

  • High Expression of Antiviral Proteins in Mucosa from Individuals Exhibiting Resistance to Human Immunodeficiency Virus. Gonzalez, Sandra Milena; Taborda, Natalia Andrea; Feria, Manuel Gerónimo; Arcia, David; Aguilar-Jiménez, Wbeimar; Zapata, Wildeman; Rugeles, María Teresa // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Background: Several soluble factors have been reported to have the capacity of inhibiting HIV replication at different steps of the virus life cycle, without eliminating infected cells and through enhancement of specific cellular mechanisms. Yet, it is unclear if these antiviral factors play a...

  • Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada. Nosyk, Bohdan; Colley, Guillaume; Yip, Benita; Chan, Keith; Heath, Katherine; Lima, Viviane D.; Gilbert, Mark; Hogg, Robert S.; Harrigan, P. Richard; Montaner, Julio S. G. // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Objective: To define a population-level cohort of individuals infected with the human immunodeficiency virus (HIV) in the province of British Columbia from available registries and administrative datasets using a validated case-finding algorithm. Methods: Individuals were identified for possible...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics